ZIMVV ZIMVIE INC

ZimVie Announces Upcoming Changes to Company's Board of Directors

ZimVie Announces Upcoming Changes to Company's Board of Directors

PALM BEACH GARDENS, Fla., March 13, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced upcoming changes to the Company's Board of Directors, including: 

  • Non-Executive Chair David King will not stand for reelection as a director upon the expiration of his current term at the Company's annual meeting of shareholders on May 7, 2025.
  • President and CEO Vafa Jamali will be appointed Chairman of the Board effective as of May 7, 2025.
  • Director Vinit Asar will be appointed Lead Independent Director effective upon the commencement of Mr. Jamali’s service as Chairman.

Retirement of Mr. King

“On behalf of ZimVie and our Board of Directors, I want to extend our deepest gratitude to David for his leadership and service as Chair during a pivotal time for the Company,” said Mr. Jamali. “His experience in the healthcare and life science sectors has been instrumental in shaping ZimVie’s strategic direction and positioning our Company for success.”

Appointment of Mr. Jamali as Chairman of the Board 

“Through his leadership as President and CEO since the spinoff three years ago, Vafa has created significant shareholder value while transforming ZimVie into a pure play dental company, substantially reduced debt to improve the company’s financial health and flexibility, and streamlined its operations,” said Mr. King. “The Board of Directors is confident Vafa will drive even stronger value for ZimVie’s stakeholders in his expanded role as Chairman.”

Appointment of Mr. Asar as Lead Independent Director

Mr. Asar has been a member of ZimVie’s Board of Directors since 2022. He currently serves as Chair of the Quality, Regulatory, and Technology Committee and as a member of each of the Audit, Corporate Governance, and Compensation Committees. Mr. Asar currently serves as the Executive Chairman of the Board of Hanger, Inc. Mr. Jamali stated, "We are honored to have Vinit serve as our Lead Independent Director. He provides valuable strategic perspective as a Board member, and I look forward to working with him in his new role.”

About ZimVie

ZimVie is a global life sciences leader in the dental market that develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. From its headquarters in Palm Beach Gardens, Florida, and additional facilities around the globe, ZimVie works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including trusted dental implants, biomaterials, and digital workflow solutions. As a worldwide leader in this space, ZimVie is committed to advancing clinical science and technology foundational to restoring daily life. For more information about ZimVie, please visit us at . Follow @ZimVie on , , , or .

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements concerning ZimVie’s expectations, plans, prospects, stakeholder value, and product and service offerings, including new product launches and potential clinical successes. Such statements are based upon the current beliefs, expectations, and assumptions of management and are subject to significant risks, uncertainties, and changes in circumstances that could cause actual outcomes and results to differ materially from the forward-looking statements. For a list and description of some of such risks and uncertainties, see ZimVie’s periodic reports filed with the U.S. Securities and Exchange Commission (SEC). These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in ZimVie’s filings with the SEC. Forward-looking statements speak only as of the date they are made, and ZimVie disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Readers of this press release are cautioned not to rely on these forward-looking statements, since there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary note is applicable to all forward-looking statements contained in this press release.

Media Contact Information:

ZimVie

Grace Flowers • 

(561) 319-6130

Investor Contact Information:

Gilmartin Group LLC

Webb Campbell • 



EN
13/03/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ZIMVIE INC

 PRESS RELEASE

ZimVie to Participate in the 24th Annual Needham Virtual Healthcare Co...

ZimVie to Participate in the 24th Annual Needham Virtual Healthcare Conference PALM BEACH GARDENS, Fla., March 25, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced management will participate in the upcoming 24th Annual Needham Virtual Healthcare Conference. Management will be presenting on Tuesday, April 8, 2025 at 3:00 p.m. Eastern Time / 12:00 p.m. Pacific Time. A live webcast of the event, as well as an archived recording will be available on ZimVie’s investor website at . About ZimVieZimVie is a global life sci...

 PRESS RELEASE

ZimVie Announces Upcoming Changes to Company's Board of Directors

ZimVie Announces Upcoming Changes to Company's Board of Directors PALM BEACH GARDENS, Fla., March 13, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced upcoming changes to the Company's Board of Directors, including:  Non-Executive Chair David King will not stand for reelection as a director upon the expiration of his current term at the Company's annual meeting of shareholders on May 7, 2025.President and CEO Vafa Jamali will be appointed Chairman of the Board effective as of May 7, 2025.Director Vinit Asar w...

 PRESS RELEASE

ZimVie Reports Fourth Quarter and Full Year 2024 Financial Results

ZimVie Reports Fourth Quarter and Full Year 2024 Financial Results FY2024 Third Party Net Sales from Continuing Operations of $449.7 millionFY2024 Net Loss from Continuing Operations of $(33.8) million; Net Loss margin of (7.5%) FY2024 Adjusted EBITDA[1] from Continuing Operations of $60.0 million; Adjusted EBITDA[1] margin of 13.3%FY2024 GAAP diluted EPS from Continuing Operations of $(1.23) and adjusted diluted EPS[1] of $0.62 PALM BEACH GARDENS, Fla., Feb. 26, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today reported financ...

 PRESS RELEASE

ZimVie to Report Fourth Quarter and Full-Year 2024 Financial Results o...

ZimVie to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025 PALM BEACH GARDENS, Fla., Feb. 12, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the fourth quarter and full-year 2024 after market close on Wednesday, February 26, 2025. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Those interested in listening to the conference call should . Participants are encouraged to register more than 15 minute...

 PRESS RELEASE

ZimVie Announces Publication of a Study Supporting the Benefits of Its...

ZimVie Announces Publication of a Study Supporting the Benefits of Its Implant Surface Technologies Data confirms ZimVie implants meet critical roughness criteria advantageous for long-term peri-implant health PALM BEACH GARDENS, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced the publication of a detailed scientific study demonstrating the surface texture of ZimVie’s premium implants may help to lower the risk of peri-implant infections when compared to other commercially available implants....

ResearchPool Subscriptions

Get the most out of your insights

Get in touch